top of page
Search
Writer's picturesiddhesh kapshikar
Oct 31, 20234 min read

Glucose Dependent Insulinotropic Receptor Market, Global Outlook and Forecast 2023-2030

The global Glucose Dependent Insulinotropic Receptor market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.


This report aims to provide a comprehensive presentation of the global market for Glucose Dependent Insulinotropic Receptor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucose Dependent Insulinotropic Receptor. This report contains market size and forecasts of Glucose Dependent Insulinotropic Receptor in global, including the following market information:


Global Glucose Dependent Insulinotropic Receptor Market Revenue, 2018-2023, 2024-2032, ($ millions)


Global top five companies in 2022 (%)


The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.

DA-1241 Segment to Reach $ Million by 2029, with a % CAGR in next six years.

The global key manufacturers of Glucose Dependent Insulinotropic Receptor include Amgen Inc, Arena Pharmaceuticals Inc, CymaBay Therapeutics Inc, Dong-A Socio Holdings Co Ltd, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Hyundai Pharmaceutical Co Ltd, Kowa Co Ltd and Merck & Co Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Glucose Dependent Insulinotropic Receptor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Glucose Dependent Insulinotropic Receptor Market, by Type, 2018-2023, 2024-2032 ($ millions)

Global Glucose Dependent Insulinotropic Receptor Market Segment Percentages, by Type, 2022 (%)


  • DA-1241

  • GSK-2041706

  • HD-0471042

  • HD-0471953

  • HOB-047

  • MBX-2982

  • Others


Global Glucose Dependent Insulinotropic Receptor Market, by Application, 2018-2023, 2024-2032 ($ millions)

Global Glucose Dependent Insulinotropic Receptor Market Segment Percentages, by Application, 2022 (%)


  • Type 2 Diabetes

  • Obesity

  • Chronic Obstructive Pulmonary Disease (COPD)

  • Dyslipidemia

  • Others


Global Glucose Dependent Insulinotropic Receptor Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)

Global Glucose Dependent Insulinotropic Receptor Market Segment Percentages, By Region and Country, 2022 (%)


  • North America

  • US

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Russia

  • Nordic Countries

  • Benelux

  • Rest of Europe

  • Asia

  • China

  • Japan

  • South Korea

  • Southeast Asia

  • India

  • Rest of Asia

  • South America

  • Brazil

  • Argentina

  • Rest of South America

  • Middle East & Africa

  • Turkey

  • Israel

  • Saudi Arabia

  • UAE

  • Rest of Middle East & Africa


Competitor Analysis

The report also provides analysis of leading market participants including:


  • Key companies Glucose Dependent Insulinotropic Receptor revenues in global market, 2018-2023 (estimated), ($ millions)

  • Key companies Glucose Dependent Insulinotropic Receptor revenues share in global market, 2022 (%)


Further, the report presents profiles of competitors in the market, key players include:


  • Amgen Inc

  • Arena Pharmaceuticals Inc

  • CymaBay Therapeutics Inc

  • Dong-A Socio Holdings Co Ltd

  • F. Hoffmann-La Roche Ltd

  • GlaxoSmithKline Plc

  • Hyundai Pharmaceutical Co Ltd

  • Kowa Co Ltd

  • Merck & Co Inc

  • Novartis AG

  • Taisho Pharmaceutical Holdings Co Ltd

  • Takeda Pharmaceutical Co Ltd

  • Yuhan Corp


Outline of Major Chapters:

Chapter 1: Introduces the definition of Glucose Dependent Insulinotropic Receptor, market overview.

Chapter 2: Global Glucose Dependent Insulinotropic Receptor market size in revenue.

Chapter 3: Detailed analysis of Glucose Dependent Insulinotropic Receptor company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Glucose Dependent Insulinotropic Receptor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.

Table of content

1 Introduction to Research & Analysis Reports 1.1 Glucose Dependent Insulinotropic Receptor Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Glucose Dependent Insulinotropic Receptor Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Glucose Dependent Insulinotropic Receptor Overall Market Size 2.1 Global Glucose Dependent Insulinotropic Receptor Market Size: 2022 VS 2030 2.2 Global Glucose Dependent Insulinotropic Receptor Market Size, Prospects & Forecasts: 2018-2030 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Glucose Dependent Insulinotropic Receptor Players in Global Market 3.2 Top Global Glucose Dependent Insulinotropic Receptor Companies Ranked by Revenue 3.3 Global Glucose Dependent Insulinotropic Receptor Revenue by Companies 3.4 Top 3 and Top 5 Glucose Dependent Insulinotropic Receptor Companies in Global Market, by Revenue in 2022 3.5 Global Companies Glucose Dependent Insulinotropic Receptor Product Type 3.6 Tier 1, Tier 2 and Tier 3 Glucose Dependent Insulinotropic Receptor Players in Global

0 views0 comments

Recent Posts

See All

Comments

bottom of page